| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.76B | 29.68B | 24.44B | 14.07B | 27.68B | 21.51B |
| Gross Profit | 17.69B | 17.68B | 12.99B | 1.07B | 20.91B | 13.28B |
| EBITDA | 12.59B | 13.35B | 8.36B | 61.58B | 18.75B | 56.66B |
| Net Income | 10.54B | 9.58B | 7.49B | 40.57B | 15.08B | 38.50B |
Balance Sheet | ||||||
| Total Assets | 162.28B | 169.97B | 165.54B | 159.85B | 233.02B | 262.38B |
| Cash, Cash Equivalents and Short-Term Investments | 68.66B | 163.87B | 67.61B | 69.48B | 52.60B | 107.52B |
| Total Debt | 15.18B | 15.18B | 15.12B | 149.00M | 183.00M | 115.00M |
| Total Liabilities | 25.24B | 28.84B | 27.90B | 29.10B | 35.63B | 47.15B |
| Stockholders Equity | 137.04B | 141.13B | 137.64B | 130.75B | 197.39B | 215.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.42B | -9.88B | -7.28B | -13.03B | -119.00M |
| Operating Cash Flow | 0.00 | 10.44B | -9.57B | -7.25B | -12.96B | 8.00M |
| Investing Cash Flow | 134.00M | 134.00M | -100.00M | 69.64B | 748.00M | 49.15B |
| Financing Cash Flow | -5.45B | -5.45B | 6.84B | -46.23B | -43.47B | -13.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥62.50B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
72 Outperform | ¥2.05T | 3.01 | 20.02% | 2.63% | 23.96% | 179.16% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥120.02B | 8.60 | 5.11% | 5.07% | -19.64% | -31.08% | |
65 Neutral | ¥23.96B | 43.28 | ― | 18.63% | 21.38% | ― | |
47 Neutral | ¥4.11B | -4.99 | 4.15% | ― | -6.60% | ― | |
44 Neutral | ¥17.53B | -12.65 | ― | ― | -21.88% | 17.12% |